Navigation Links
Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution

PHILADELPHIA, June 25, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.

Cortellis for Regulatory Intelligence is a comprehensive regulatory solution  that  helps regulatory affairs professionals make timely and more informed decisions by providing them with exclusive regulatory information for multi-country filings, comparing existing and emerging competitive products, preparing for committee meetings and inspections, and keeping up-to-date on regulatory changes as they happen.

"Our business depends on understanding the global regulatory landscape and the continually evolving submission approval requirements," said Rick Riegel, CEO of Liquent. "By using Cortellis for Regulatory Intelligence, we can assure our clients that our knowledge is supplemented by the industry's leading regulatory intelligence database.  In addition, it provides the opportunity to explore new ways of incorporating that knowledge into our own solutions via the available API's in the Cortellis platform."

This new regulatory intelligence solution enables companies to more quickly and easily leverage the comprehensive and enhanced regulatory content via Thomson Reuters Cortellis™, the premiere Life Sciences platform.

Cortellis delivers impressive search speeds and more relevant results due to an all-new search engine in a highly intuitive user interface. The search engine allows for rapid free-text searching, making it possible for users to search across the platform's entire regulatory database without the need to design complex search strategies, while custom filters are available to increase accuracy. Cortellis will also make valuable information more accessible and is compatible with mobile devices, including smartphones and tablet devices, providing a more interactive user experience, and the freedom to stay informed while on the go.

Here is what some pharmaceutical professionals have said after using Cortellis for Regulatory Intelligence:

  • "Cortellis for Regulatory Intelligence is 'remarkably' different in a good way."
  • "This search platform is so different compared to standard IDRAC, it's almost incomparable! I think I will use it in a completely different way. Very nice!"
  • "We have explored Cortellis for Regulatory Intelligence and we are very pleased with the easy sorting capabilities."

"We are very excited to announce the launch of Cortellis for Regulatory Intelligence and think it has the power to transform the way the industry approaches and utilizes pharmaceutical regulatory intelligence," said Jon Brett-Harris, executive vice president of Life Sciences at Thomson Reuters. "The industry's needs for accessing regulatory intelligence are changing and Thomson Reuters is responding to the new demands. Cortellis for Regulatory Intelligence not only allows our customers to make stronger, better informed decisions, but will greatly improve their ability to be compliant."

To learn more about Cortellis for Regulatory Intelligence, visit or stop by our booth, #3001, at the DIA Annual Meeting between June 24 - 28.

Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to

SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
3. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
4. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
5. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
6. Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
7. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
8. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
9. Cardinal Health Specialty Solutions Launches PathWareâ„¢ Decision Support Transaction Solutions
10. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):